54
Views
1
CrossRef citations to date
0
Altmetric
Letter

Assessment of arterial stiffness in patients with inactive and active Behçet’s disease: comments on the article by Yilmaz et al

, , , &

References

  • Yilmaz S, Celik G, Esmen S. Assessment of arterial stiffness in patients with inactive and active Behçet’s disease. Scand J Rheumatol 2014;43:63–9.
  • Balta I, Akbay G, Kalkan G, Eksioglu M. Demographic and clinical features of 521 Turkish patients with Behçet’s disease. Int J Dermatol. Published online: 22 August 2013. doi: 10.1111/j.1365-4632.2012.05756.x.
  • Tursen U. [Activation markers in Behcet disease], in Turkish. Turkderm 2009;43:74–86.
  • Balta I, Balta S, Demirkol S, Ekiz O. Peripheral arterial disease in patients with Behçet’s disease. Rheumatol Int. Published online: 28 March 2013. doi: 10.1007/s00296-013-2729-9.
  • Balta I, Balta S, Koryurek OM, Demırkol S, Celik T, Akbay G, Mean platelet volume is associated with aortic arterial stiffness in patients with Behçet’s disease without significant cardiovascular involvement. J Eur Acad Dermatol Venereol. Published online: 25 October 2013. doi: 10.1111/jdv.12297.
  • Balta I, Balta S, Demirkol S, Celik T, Ekiz O, Cakar M, Aortic arterial stiffness is a moderate predictor of cardiovascular disease in patients with psoriasis vulgaris. Angiology 2014;65:74–8.
  • Balta S, Demırkol S, Kucuk U, Arslan Z, Unlu M, Yesil FG. Epicardial adipose tissue should be evaluated with other ınflammatory markers in patients with subclinical hypothyroidism. Med Princ Pract 2013;22:603.
  • Obuobie K, Smith J, Evans LM, John R, Davies JS, Lazarus JH. Increased central arterial stiffness in hypothyroidism. J Clin Endocrinol Metab 2002;87:4662–6.
  • Altun B, Bulucu F, Demirbas S, Karaman M, Ay SA, Cakar M, The relationship between some of the cardiovascular risk factors and arterial stiffness parameters in essentially hypertensive patients. Clin Exp Hypertens 2013;35:444–8.
  • Balta S, Cakar M, Demirkol S, Unlu M, Kucuk U, Arslan Z. Arterial stiffness itself without other inflammatory markers may not provide information to clinicians. J Clin Hypertens (Greenwich) 2013; 15:303.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.